Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis
Multiple sclerosis (MS) is a debilitating neurodegenerative disease characterized by demyelination and neuronal loss. Traditional therapies often fail to halt disease progression or reverse neurological deficits. Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative a...
Saved in:
Main Authors: | David Qixiang Chen, José Adalberto Inzunza Domínguez, Juan Manuel Valle Uzeta, Abhiram P. Pushparaj, Jonathan E. Dickinson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1535782/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Neuroplasticity in multiple sclerosis
by: Yavor Yalachkov, et al.
Published: (2025-02-01) -
Exploring the Pathophysiology, Diagnosis, and Treatment Options of Multiple Sclerosis
by: Simone Lorenzut, et al.
Published: (2025-01-01) -
PSYCHEDELICS: CLINICAL EVIDENCE AND THERAPEUTIC MECHANISMS IN PSYCHIATRY
by: JANI KAJANOJA, OSKARI KANTONEN, JUUSO KÄHÖNEN
Published: (2024-11-01) -
Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy
by: Joseph A. Zamaria, et al.
Published: (2025-02-01) -
LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
by: J Van Der Walt, et al.
Published: (2023-11-01)